Aldsupport - aldsupport.org - ClinicalTrials.gov: Adrenoleukodystrophy

Latest News:

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants 17 Jun 2013 | 09:00 pm

Conditions:   Hematologic Malignancies;   Inborn Errors of Metabolism Disorders;   Immune Deficiencies Intervention:   Biological: CliniMACS CD34 Reagent System Sponsors:   Duke University;   Joanne K...

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants 17 Jun 2013 | 09:00 pm

Conditions:   Hematologic Malignancies;   Inborn Errors of Metabolism Disorders;   Immune Deficiencies Intervention:   Biological: CliniMACS CD34 Reagent System Sponsors:   Duke University;   Joanne K...

Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders 21 Jun 2012 | 12:00 am

Conditions:   Lysosomal Storage Disease;   Peroxisomal Disorder Interventions:   Drug: Campath-1H;   Drug: Clofarabine;   Drug: Melphalan;   Radiation: Total Body Irradiation with Marrow Boosting;   B...

Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders 21 Jun 2012 | 12:00 am

Conditions:   Lysosomal Storage Disease;   Peroxisomal Disorder Interventions:   Drug: Campath-1H;   Drug: Clofarabine;   Drug: Melphalan;   Radiation: Total Body Irradiation with Marrow Boosting;   B...

Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders 21 Jun 2012 | 12:00 am

Conditions:   Lysosomal Storage Disease;   Peroxisomal Disorder Interventions:   Drug: Campath-1H;   Drug: Clofarabine;   Drug: Melphalan;   Radiation: Total Body Irradiation with Marrow Boosting;   B...

Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders 21 Jun 2012 | 12:00 am

Conditions:   Lysosomal Storage Disease;   Peroxisomal Disorder Interventions:   Drug: Campath-1H;   Drug: Clofarabine;   Drug: Melphalan;   Radiation: Total Body Irradiation with Marrow Boosting;   B...

Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders 21 Jun 2012 | 12:00 am

Conditions:   Lysosomal Storage Disease;   Peroxisomal Disorder Interventions:   Drug: Campath-1H;   Drug: Clofarabine;   Drug: Melphalan;   Radiation: Total Body Irradiation with Marrow Boosting;   B...

Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders 21 Jun 2012 | 12:00 am

Conditions:   Lysosomal Storage Disease;   Peroxisomal Disorder Interventions:   Drug: Campath-1H;   Drug: Clofarabine;   Drug: Melphalan;   Radiation: Total Body Irradiation with Marrow Boosting;   B...

Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders 21 Jun 2012 | 12:00 am

Conditions:   Lysosomal Storage Disease;   Peroxisomal Disorder Interventions:   Drug: Campath-1H;   Drug: Clofarabine;   Drug: Melphalan;   Radiation: Total Body Irradiation with Marrow Boosting;   B...

Exercise Study of Function and Pathology for Women With X-linked Adrenoleukodystrophy 8 May 2012 | 04:00 am

Condition:   X-linked Adrenoleukodystrophy Intervention:   Behavioral: exercise training Sponsors:   Hugo W. Moser Research Institute at Kennedy Krieger, Inc.;   Hugo W. Moser Research Institute at Ke...

Related Keywords:

adrenoleukodystrophy

Recently parsed news:

Recent searches: